Qingyu Xiu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qingyu Xiu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Hao Tang
Department of Respiratory Medicine, Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai, 200003, China
2 shared publicationsB. Li
1 shared publicationBing Li
1 shared publicationGabriela P. Saborío
Vifor Pharma SA
1 shared publicationH. Tang
Dept of Respiratory Disease, Changzheng Hospital, Shanghai, China
1 shared publication- Hao Tang
Department of Respiratory Disease, Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai 200003, China
1 shared publication
Latest Publications
- 5 June 2015
- Published by Springer Nature in Lung
- Vol. 193 (4) , 513-519
Efficacy and Safety of OM-85 in Patients with Chronic Bronchitis and/or Chronic Obstructive Pulmonary Disease
Recurrent acute exacerbations are generally associated with accelerated decline of lung function and characterized by reduced physical activity and worsening of clinical status in patients with chronic obstructive pulmonary disease (COPD). Effective practices and therapies aimed at preventing acute exacerbations are continuously under investigation by healthcare providers. This double-blind, placebo-control, randomized clinical trial sought to evaluate the preventive effect of a bacterial lysate (OM-85) on acute exacerbations in patients with COPD or chronic bronchitis in China.
- 5 June 2015
- Published by Springer Nature in Lung
- Vol. 193 (4) , 513-519
Efficacy and Safety of OM-85 in Patients with Chronic Bronchitis and/or Chronic Obstructive Pulmonary Disease
Recurrent acute exacerbations are generally associated with accelerated decline of lung function and characterized by reduced physical activity and worsening of clinical status in patients with chronic obstructive pulmonary disease (COPD). Effective practices and therapies aimed at preventing acute exacerbations are continuously under investigation by healthcare providers. This double-blind, placebo-control, randomized clinical trial sought to evaluate the preventive effect of a bacterial lysate (OM-85) on acute exacerbations in patients with COPD or chronic bronchitis in China.
- 9 April 2010
- Published by Elsevier in Heart & Lung
- Vol. 40 (2) , 168-171
Rosai–Dorfman disease of multiple organs, including the epicardium: An unusual case with poor prognosis
- 9 April 2010
- Published by Elsevier in Heart & Lung
- Vol. 40 (2) , 168-171
Rosai–Dorfman disease of multiple organs, including the epicardium: An unusual case with poor prognosis
- Open Access
- 31 March 2010
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 35 (4) , 757-760
YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E
The chitinase-like protein YKL-40, which binds chitin but lacks chitinase activity, has been found to be either the cause or a biomarker for asthma. The aim of our study was to investigate whether serum YKL-40 levels are increased in Chinese patients with asthma and identify its correlation to acute exacerbation, total serum immunoglobulin (Ig)E, the percentage of peripheral blood eosinophils and lung function. We quantified serum YKL-40 levels, total IgE levels and peripheral blood eosinophil percentages in patients with asthma, as well as in controls from the communities surrounding our hospital. The lung function of asthma subjects was also measured. Our data showed that the serum YKL-40 levels were significantly elevated in patients with asthma compared with controls and, when the asthma subjects were stratified, serum YKL-40 levels in the exacerbation group were higher than those in the stable and control groups. In addition, serum YKL-40 levels correlated positively with total serum IgE levels and the percentage of peripheral blood eosinophils, but correlated inversely with lung functions. Thus, we conclude that YKL-40 is found in increased quantities in the serum of Chinese patients with asthma, and its level correlates with exacerbation attacks, indicating that high levels of serum YKL-40 may be a biological characteristic of the exacerbation of asthma.
- 31 March 2010
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 35 (4) , 757-760
Open AccessYKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E
The chitinase-like protein YKL-40, which binds chitin but lacks chitinase activity, has been found to be either the cause or a biomarker for asthma. The aim of our study was to investigate whether serum YKL-40 levels are increased in Chinese patients with asthma and identify its correlation to acute exacerbation, total serum immunoglobulin (Ig)E, the percentage of peripheral blood eosinophils and lung function. We quantified serum YKL-40 levels, total IgE levels and peripheral blood eosinophil percentages in patients with asthma, as well as in controls from the communities surrounding our hospital. The lung function of asthma subjects was also measured. Our data showed that the serum YKL-40 levels were significantly elevated in patients with asthma compared with controls and, when the asthma subjects were stratified, serum YKL-40 levels in the exacerbation group were higher than those in the stable and control groups. In addition, serum YKL-40 levels correlated positively with total serum IgE levels and the percentage of peripheral blood eosinophils, but correlated inversely with lung functions. Thus, we conclude that YKL-40 is found in increased quantities in the serum of Chinese patients with asthma, and its level correlates with exacerbation attacks, indicating that high levels of serum YKL-40 may be a biological characteristic of the exacerbation of asthma.
- 29 September 2007
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 468 (1) , 92-99
Cyclooxygenase-2 induction requires activation of nuclear factor of activated T-cells in Beas-2B cells after vanadium exposure and plays an anti-apoptotic role
- 29 September 2007
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 468 (1) , 92-99
Cyclooxygenase-2 induction requires activation of nuclear factor of activated T-cells in Beas-2B cells after vanadium exposure and plays an anti-apoptotic role